Third Pole Therapeutics said that it has received two new patents from the US Patent and Trademark Office covering its inhaled nitric oxide (iNO) delivery systems through at least 2038. The patents (No. 10,286,176 and No. 10,328,228) are titled “Systems and Methods for Generating Nitric Oxide” and “Systems and Methods for Ambulatory Generation of Nitric Oxide.”
The iNO delivery systems, which generate NO on demand with no need for compress gas cylinders, are now protected by a total of 19 patents, and a number of foreign patents are pending, the company said.
Third Pole Therapeutics founder and CEO David Zapol commented, “Third Pole’s innovative and disruptive delivery system produces pure iNO for therapeutic use from air using a simple, convenient, lightweight, and proprietary technology capable of bedside and portable use. Combined with our exclusive licenses from Massachusetts General Hospital (MGH), the two new US patents provide Third Pole with unique systems and methods to make iNO available in more settings and to expand worldwide access to pharmaceutical iNO.”
Read the Third Pole Therapeutics press release.
